All In Biotech

Drug Trial Radar · NCT01095211

B-vitamins Treatment for Improvement of Cognitive Function

Effect of B-Vitamins on Cognitive Function in Elderly People

Last checked: Nov 20, 2026Latest source record: May 11, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

79

Actual

Start

Jan 2003

Primary completion

Sep 2005

Study completion Dec 2009

Sponsor

Lead sponsor
Universität des SaarlandesAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Geriatrische Rehaklinik
First posted
Mar 30, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Observation studies documented a correlation between plasma concentrations of homocysteine and cognitive decline with age. The study hypothesis was that high doses of B-vitamins (as effective homocysteine lowering treatment) can improve cognitive function in elderly people.

Conditions

  • Cognitive Function
  • Metabolic Improvements

Interventions

  • B-vitamin complexDrug

    5 mg Folic acid, plus 1 mg cyanocobalamin and 40 mg vitamin B6) oral/ day. The placebo capsule contained 400 mg of mannitol: aerosil (99.5: 0.5). In addition, 1 mg/s.c cyanocobalamin daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cognitive functionTime frame: baseline and 45 days later

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Dr. Eckert-

    Sankt Ingbert, Saarland, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.